Joint Service Chemical & Biological Defense Program Overview ...

More documents

Recommendations

Info

ACTDs 64 What is an ACTD? Advanced Concept Technology Demonstrations (ACTDs) are an integral element of reforming the acquisition process and accelerating the application of mature technologies to solve military problems. The ACTD process permits the early evaluation of mature advanced technology to meet the needs of the warfighter. Evaluations are accomplished by the warfighter to determine military utility before a commitment is made to proceed with formal acquisition. ACTDs also allow the warfighter to develop and refine operational concepts to take full advantage of new capabilities. ACTDs provide sustainment support for two years for the continued evaluation of the technology after which it can be transitioned into an appropriate phase of formal acquisition. ACTDs are sponsored and executed jointly by a team composed of an operational user and a technology developer, with approval and oversight from the Deputy Under Secretary of Defense for Advanced Technology (DUSD(AT)). ACTDs are normally conducted under an Integrated Product Team (IPT) approach that considers the operational needs, training, supportability, and other related issues, as well as concerns of the acquisition community. The sponsor is responsible for defining the mission and scenario, concept of operations, operational forces, and post-demonstration evaluation criteria. The acquisition activity is responsible for day-to-day technical and program management. A range of conclusions can result from an ACTD from “don’t acquire” to “procurement,” or a mid-range solution that places the product into some mid-range posture within the acquisition cycle. The ACTD concept has been used to good effect within the Joint CBD program, and its use continues today. Current CBD programs operating under the ACTD concept are described below. Air Base/Port Biological Detection (Portal Shield) Objective: To provide interim capability to detect, alarm/warn/dewarn, and presumptively identify BW attack. Evaluate the military utility of sensor network, RF links, alarms, and assessment processes. Sponsor: CINCPAC and CENTCOM ACTD Scenario: BW attack on an airbase/port facility. Status: ACTD completed in FY99, and transitioned into procurement as a result of Joint Chiefs of Staff (JCS) directed buy. Program procured 70 sensors in FY99 and will procure 97 in FY01.
Joint Biological Remote Early Warning System (JBREWS) Objective: To evaluate the utility of an early warning capability that allows a compressed decision cycle to warn, report and protect deployed forces employing a system of distributive BW agent sensors. Components include the JBREWS architecture, the Deployable Unit Biological Detection System (DUBDS), the Short Range-Biological Standoff Detection System (SR-BSDS), and the data link from legacy biological detection systems. Sponsor: EUCOM ACTD Scenario: BW missile attacks on ground maneuver force in an assembly area Status: Completed in FY00 Chemical and Biological Individual Sampler (CBIS) Objective: Improved detection and identification capabilities will provide greater awareness of immediate chemical exposure risk. More precise identification of both short- or long-term and low-level doses resulting in improved situational awareness, treatment and record keeping. Additional payoffs will include ability to perform realtime analysis of agents and toxic industrial materials (TIMs), communication of exposure information to command centers, and increased battlefield awareness and intelligence. Sponsor: Joint Forces Command ACTD Scenario: TBD Status: The CBIS Phase I effort (COTS passive chemical sampling only) has been initiated with live agent testing of four COTS samplers and analysis of available portable analytical equipment. The CBIS Blue Ribbon Panel has selected technically promising Phase II proposals. Phase II efforts employ emerging technologies for active chemical and biological samplers/analyzers. Restoration of Operations at Fixed Sites (RestOps) Objective: Integrate and demonstrate mature technologies and tools used to mitigate adverse effects and restore operations at a fixed site before, during, or after an attack of either CW or BW, in order to support operational war plans. Develop, improve, and integrate concepts of operations (CONOPS) and tactics, techniques, and procedures (TTPs) for executing RestOps contingencies at a fixed site. Capture lessons learned for incorporation into joint, multiservice, and service doctrinal institutions. Evaluate the science and technologies available to support identification of potential improvements in current U.S. policy for CONUS and OCONUS RestOps scenarios. Sponsor: PACOM ACTD Scenario: Chemical or biological attack on an airfield or seaport. Status: ACTD management coordination and stand-up completed in FY00. Initial technology evaluations conducted and preliminary testing conducted in FY01. Preliminary technology demonstration to be conducted in FY02. ACTDs 65
Page 2 and 3:
Preface In 1993, Congress passed Pu
Page 4 and 5:
Global Threat 2 A Dangerous World
Page 6 and 7:
Support to Joint Vision 2020 4 Domi
Page 8 and 9:
Integrated Approach to Counter the
Page 10 and 11:
ACADA 8 Automatic Chemical Agent De
Page 12 and 13:
Artemis 10 Artemis formerly Joint S
Page 14 and 15:
BIDS 12 Biological Integrated Detec
Page 16 and 17: ICAM 14 Improved Chemical Agent Mon
Page 18 and 19: JBPDS 16 Joint Biological Point Det
Page 20 and 21: JCAD 18 Joint Chemical Agent Detect
Page 22 and 23: JSLNBCRS 20 Joint Service Lightweig
Page 24 and 25: JSLSCAD 22 Joint Service Lightweigh
Page 26 and 27: JWARN 24 Joint Warning and Reportin
Page 28 and 29: NBCRS Modifications 26 NBC Reconnai
Page 30 and 31: CBPS 28 Chemical Biological Protect
Page 32 and 33: CP DEPMEDS 30 Chemically Protected
Page 34 and 35: CPS Backfit/SCPE 32 Collective Prot
Page 36 and 37: JPACE/JSAM 34 Joint Protective Airc
Page 38 and 39: JSGPM 36 Joint Service General Purp
Page 40 and 41: JSLIST/JSLIST P3I 38 Joint Service
Page 42 and 43: JTCOPS 40 Joint Transportable Colle
Page 44 and 45: JBAIDS 42 Joint Biological Agent Id
Page 46 and 47: Medical Vaccines 44 Medical Biologi
Page 48 and 49: Medical CB Products 46 Medical CW/B
Page 50 and 51: Medical Pretreatments 48 Chemical W
Page 52 and 53: Medical CB Therapeutics and Diagnos
Page 54 and 55: JSFXD 52 Joint Service Fixed Site D
Page 56 and 57: JSSED 54 Joint Service Sensitive Eq
Page 58 and 59: MDS 56 Modular Decontamination Syst
Page 60 and 61: Sorbent 58 Sorbent Decontamination
Page 62 and 63: Modeling and Simulation 60 Modeling
Page 64 and 65: Science & Technology 62 Lead Servic
Page 68 and 69: Joint Service CB Defense Doctrine a
Page 70 and 71: Joint Management Structure 68 The N
Page 72 and 73: JSIG/JSMG Management 70 Joint Servi
Page 74 and 75: Army CBD Proponent Structure 72 Arm
Page 76 and 77: Navy CBD Proponent Structure 74 Nav
Page 78 and 79: Funding 76 FY01 CBDP Funding Distri
Page 80 and 81: Acronyms 78 AA Abbreviate Analysis
Page 82 and 83: Points of Contact 80 Office of the
Page 84 and 85: Points of Contact 82 Joint Service
Page 86 and 87: Points of Contact 84 Joint Science
Page 88: Requests for this document should b
show all

Joint Service Chemical & Biological Defense Program Overview ...

Create successful ePaper yourself

Delete template?

Save as template?